Related content

High-dose 3-dimensional conformal radiotherapy with concomitant vinorelbine plus carboplatin in patients with non-small cell lung cancer: A feasibility study

By                    

Oncology Letters, Vol. 2, Iss. 4, 2011-01 ,pp. : 669-674

Spandidos Publications

Access to resources Recommend Favorite

Gemcitabine and low dose carboplatin in the treatment of elderly patients with advanced non-small cell lung cancer

By Maestu I.   Gomez-Aldaravi L.   Torregrosa M.D.   Camps C.   Llorca C.   Bosch C.   Gomez J.   Giner V.   Oltra A.   Albert A.  

Lung Cancer, Vol. 42, Iss. 3, 2003-12 ,pp. : 345-354

Elsevier

Access to resources Recommend Favorite

Phase II trial of dose-dense chemotherapy followed by dose-intense erlotinib for patients with newly diagnosed metastatic non-small cell lung cancer

By                

International Journal of Oncology, Vol. 43, Iss. 6, 2013-01 ,pp. : 2057-2063

Spandidos Publications

Access to resources Recommend Favorite

Role of gross tumor volume on outcome and of dose parameters on toxicity of patients undergoing chemoradiotherapy for locally advanced non-small cell lung cancer

By De Petris Luigi   Lax Ingmar   Sirzén Florin   Friesland Signe  

Medical Oncology, Vol. 22, Iss. 4, 2005-12 ,pp. : 375-381

Humana Press, Inc

Access to resources Recommend Favorite

Aggravation of dyspnea in stage I non-small cell lung cancer patients following stereotactic body radiotherapy: Is there a dose-volume dependency?

By Paludan Merete   Traberg Hansen Anders   Petersen Jørgen   Grau Cai   Høyer Morten  

Acta Oncologica, Vol. 45, Iss. 7, 2006-09 ,pp. : 818-822

Informa Healthcare

Access to resources Recommend Favorite